Monoclonal Anti-Dengue Virus Type 1, Clone E18 (produced in vitro)
Applications
Mouse monoclonal antibody that binds to domain I-II of the envelope glycoprotein of dengue virus type 1 was purified from hybridoma supernatant by protein G affinity chromatography.
Emerging infectious disease research
Biosafety Level
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Isolation
Mouse monoclonal antibody that binds to domain I-II of the envelope glycoprotein of dengue virus type 1 was purified from hybridoma supernatant by protein G affinity chromatography. The B cell hybridoma was generated by the fusion of P3X63.Ag.8.6.5.3 BALB/c mouse myeloma cells with immunized mouse splenocytes.
Product Format
frozen Each vial of VR-3209 contains approximately 125.0µg of purified monoclonal antibody in PBS.
Storage Conditions
-20°C or colder
Comments
Mouse monoclonal antibody that binds to domain I-II of the envelope glycoprotein of dengue virus type 1 was purified from hybridoma supernatant by protein G affinity chromatography. The B cell hybridoma was generated by the fusion of P3X63.Ag.8.6.5.3 BALB/c mouse myeloma cells with immunized mouse splenocytes.
VR-3209 is reactive with dengue virus type 1, Hawaii by immunofluorescence and ELISA.
Effect on Host
Mouse monoclonal antibody that binds to domain I-II of the envelope glycoprotein of dengue virus type 1 was purified from hybridoma supernatant by protein G affinity chromatography. The B cell hybridoma was generated by the fusion of P3X63.Ag.8.6.5.3 BALB/c mouse myeloma cells with immunized mouse splenocytes.
